Cyrano Therapeutics
Washington, US · Delaware corporation · 2 known investors
Develops regenerative therapy for persistent smell loss, currently in Phase 2 clinical trials.
Healthtech
Founders & leadership
RG
Richard GeoffrionExecutive Officer, Director
GB
Gerry BrunkDirector
TK
Takahide KodaDirector
RH
Robert HenkinDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$4.1MraisedNov 2020 · 11 investors · Other Health CareRule 506(b)
▶$4.1MraisedNov 2020 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard GeoffrionExecutive Officer, Director
- Gerry BrunkDirector
- Takahide KodaDirector
- Robert HenkinDirector
- Offering amount
- $12.8M
- Amount sold
- $4.1M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.